Sign in

Walid Gellad

@walidgellad.bsky.social
747 followers 141 following 13 posts
PostsRepliesMedia
Reposted by Walid Gellad
jamelle @jamellebouie.net · 28/06/2026
shoutout to everyone who recommended Apteka in pittsburgh. one of the best meals i have had this year
63198776
Reposted by Walid Gellad
Asawin Suebsaeng @swin24.bsky.social · 03/07/2026
Pittsburgh is awesome, man. You all have an amazing american city here. I want to come back asap
4666623
Walid Gellad @walidgellad.bsky.social · 06/06/2026
I haven’t posted in a while, so just letting everyone know things are good here.
030
Walid Gellad @walidgellad.bsky.social · 24/04/2026
to those who are focusing on the secondary outcome of self reported time to clinical recovery, remember this is open label. Can’t draw any firm conclusions, as the authors state Also remember EPIC-SR, placebo controlled, did not show a difference in median time to sustained alleviation of symptoms
110
Walid Gellad @walidgellad.bsky.social · 22/04/2026
Breaking into bluesky to say that PANORAMIC data on paxlovid‘s (lack of) efficacy in reducing Covid hospitalizations and death in vaccinated cohort is out The drug’s efficacy in this group was so exaggerated by those who should have known better but had reasons not to www.nejm.org/doi/full/10....
nejm.org
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients | NEJM
Nirmatrelvir–ritonavir has been shown to reduce progression to severe illness from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in unvaccinated high-risk outpatients. The effectiven...
140
Reposted by Walid Gellad
Sarah Karlin-Smith @sarahkarlin-smith.bsky.social · 21/02/2025
this study made me think of @walidgellad.bsky.social www.cidrap.umn.edu/covid-19/dat...
cidrap.umn.edu
Data suggest Paxlovid doesn't reduce severe COVID in older, vaccinated adults
121
Reposted by Walid Gellad
Alexander Tin @alexander-a-tin.bsky.social · 10/01/2025
Remember E. coli outbreak linked to onions in McDonald's Quarter Pounders? FDA inspectors found dozens of violations at supplier, like: - ignoring biofilm/debris buildup - not using handwashing sinks - cleaning chemicals getting on food www.cbsnews.com/news/fda-rep...
cbsnews.com
FDA finds little handwashing, dirty equipment at McDonald's supplier linked to E. coli outbreak
More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.
12613
Reposted by Walid Gellad
Stacie Dusetzina @dusetzinas.bsky.social · 29/12/2024
Truly, one of the best changes to Medicare in decades. If you need a very expensive medicine (or a lot of medicine) and you are on Medicare you now have a hard cap on spending starting on 1/1. That is awesome.
1296
Reposted by Walid Gellad
Scott Gottlieb, MD @scottgottliebmd.bsky.social · 27/12/2024
FDA transfers regulatory oversight of medical maggots and leaches from its device center (the organisms previously regulated as medical devices) to biologics center public-inspection.federalregister.gov/2024-31266.p... More on their clinical applications here pmc.ncbi.nlm.nih.gov/articles/PMC...
43013
Reposted by Walid Gellad
Michael L. Barnett @mlbarnett.bsky.social · 19/12/2024
Some news ... I'm thrilled to announce that I'll be joining the Brown School of Public Health as a Professor of Health Services Policy & Practice this upcoming summer, 2025! I'm excited for the move and the opportunity to grow my research in new directions. hspp.sph.brown.edu
hspp.sph.brown.edu
Health Services, Policy & Practice | School of Public Health | Brown University
Imagine a world where everyone has access to quality health care—regardless of their social status, ethnicity or financial situation.
191154
Reposted by Walid Gellad
Jacob Wallace @jacobwswallace.bsky.social · 16/12/2024
I'm looking for a third paper for a Medicaid managed care-focused panel for ASHE. DM me if interested! Please RT, I'm new to the blue skies...
32334
Reposted by Walid Gellad
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 02/12/2024
CP3 Associate Director Dr. Katie Suda is learning from past #drugshortages to help mitigate future ones. take a look at her most recent paper comparing US vs Canada. jamanetwork.com/journals/jam...
jamanetwork.com
Differences in Drug Shortages in the US and Canada
This longitudinal cross-sectional study compares how frequently reports of drug-related supply chain issues were associated with drug shortages in the US compared with Canada.
032
Reposted by Walid Gellad
Antonio Ciaccia @aciaccia.bsky.social · 26/11/2024
When prescription drug costs are subjectively set by conflicted intermediates who profit off higher prices and misaligned incentives, the sticker shock isn’t really a shock at all. www.wsj.com/health/healt... @wsj.com
wsj.com
Same Drug, 2,200 Different Prices
Middlemen negotiate widely different prices for prescriptions, depending on your Medicare insurance plan.
1549298
Reposted by Walid Gellad
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 26/11/2024
🆕from @LilyBessette & CP3's @TimAndersonMD - a third of patients eligible for weight loss 💊would have been excluded from their clinical trials. Read more @JAMAInternalMed jamanetwork.com/journals/jam...
jamanetwork.com
Generalizability of Clinical Trial Findings of Novel Weight Loss Medications
This cross-sectional study investigates the extent to which individuals meeting label criteria for novel weight loss medications may not have been included in pivotal trials.
012
Reposted by Walid Gellad
Scott Gottlieb, MD @scottgottliebmd.bsky.social · 26/11/2024
Reprising this from my AEI colleague Ben Ippolito on the cost of Medicare coverage for GLP-1s. CMS appears to see writing on wall here: As additional indications are approved, most Medicare recipients will get coverage for other co-morbidities. Also, Semaglutide subject to IRA price controls in 2027
13014
Reposted by Walid Gellad
Scott Gottlieb, MD @scottgottliebmd.bsky.social · 22/11/2024
My article in @statnews.bsky.social on GLP-1 compounding: the @fda.gov needs to maintain the integrity of its authorities — and the implementation of the Drug Quality and Security Act (DQSA). www.statnews.com/2024/11/19/f...
24310
Reposted by Walid Gellad
Stacie Dusetzina @dusetzinas.bsky.social · 21/11/2024
I do hope it sticks this time @katiepalmer.bsky.social! Nice comments from @walidgellad.bsky.social and @scottgottliebmd.bsky.social.
statnews.com
Bluesky is the new destination for X/Twitter’s health and science community. Here's why
#MedTwitter is migrating en masse from X to Bluesky, suddenly making it an essential hub for scientific discourse. Here's why.
1198
Reposted by Walid Gellad
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 19/11/2024
ICYMI: Our team previously showed ⬆️prices for indomethacin suppositories. Now, we found wide variation in hospital charges for this drug - charges passed to patients b/c the suppositories are excluded from Medicare Parts B&D. More in JAMA Network Open jamanetwork.com/journals/jam...
011
Reposted by Walid Gellad
Alexander Tin @alexander-a-tin.bsky.social · 02/03/2024
Oral naltrexone is one of main medications doctors can turn to for treating alcohol use disorder FDA now lists it in shortage, with multiple manufacturers citing a "Shortage of an active ingredient" or "Demand increase for the drug" www.accessdata.fda.gov/scripts/drug...
A screenshot of tables that reads in part: "Accord Healthcare Inc. (New 02/29/2024) Company Contact Information: 866-941-7875, option 2 Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA) Tablet, 50 mg (NDC 16729-081-01)	Not Available. Resupply TBD		Shortage of an active ingredient Tablet, 50 mg (NDC 16729-081-10)	Available and shipping Customers Sales Orders		Shortage of an active ingredient Elite Laboratories, Inc. (New 02/29/2024) Company Contact Information: 800-397-9228 Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA) Tablet, 50 mg (NDC 51224-206-50)	Available	Marketed by Tagi Pharma Tablet, 50 mg (NDC 51224-206-30)	Available	Marketed by Tagi Pharma Tablet, 50 mg (NDC 68094-909-50)	Available	Marketed by Precision Dose Tablet, 50 mg (NDC 68094-909-30)	Available	Marketed by Precision Dose SpecGx LLC (New 02/29/2024) Company Contact Information: 800-325-8888 Presentation	A
052
Walid Gellad @walidgellad.bsky.social · 02/03/2024
I’m not posting much here, but I’d like to point out that it is tweets like this that exaggerate study findings. Stat shouldn’t do this. This study design cannot measure impact of COVID on cognition. Rather it compares cognition in those with and without COVID/symptoms with no baseline measure.
040
Reposted by Walid Gellad
Coleman Drake @colemandrake.bsky.social · 09/10/2023
Prospective PhD students: Applications are now open for the #PittHPM Health Services Research and Policy PhD program! Join #PittPubHealth for info sessions in October (virtual) and November 3 (in-person)
sph.pitt.edu
Admissions Events | School of Public Health
Prospective Bachelor's Students Register for an in-person or virtual information session for the Bachelor of Science in Public Health program through Pitt Undergraduate Admissions.
101
Walid Gellad @walidgellad.bsky.social · 27/09/2023
The Department of Health Policy and Management at Pitt is hiring tenure track faculty in policy and health services research. Apply. French fries on salads. cfopitt.taleo.net/careersection/pit…
084
Reposted by Walid Gellad
Adrianna McIntyre @adrianna.bsky.social · 16/08/2023
Re-upping this since the health policy contingent is slowly but steadily growing: BlueSky has "feeds," which are sort of like Twitter's lists, but you typically need to use a keyword (or key emoji) to have a post feature in the feed. I created a health policy feed here:
21310
Reposted by Walid Gellad
Stacie Dusetzina @dusetzinas.bsky.social · 17/07/2023
Welcome, @bnrome.bsky.social ! Check out the health policy list and instructions for contributing to that feed. You can pin the feed to easily get back to it.
011
Walid Gellad @walidgellad.bsky.social · 15/07/2023
Original Humira’s list price grew so much that its actual price after rebates to Medicaid was zero. (It will be fascinating to see what happens in Medicare with inflation rebate). #healthpolicy jamanetwork.com/journals/jamanetwor…
041
Reposted by Walid Gellad
Dmitriy @dmitriy.bsky.social · 13/07/2023
ICER's report on sickle cell disease🧪 is out today! Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M #healthpolicy
icer.org
054
Walid Gellad @walidgellad.bsky.social · 10/07/2023
“Another hospital attempted to charge a patient a facility fee of up to $350 for a telehealth visit because the doctor was on hospital property.” 🙃 #healthpolicy www.statnews.com/2023/07/07/hospita…
statnews.com
New Biden initiative targets controversial hospital 'facility fees' that often surprise patients
A new Biden administration initiative requires hospitals to “make information about these facility fees publicly available to consumers.”
064